Form EFFECT XORTX Therapeutics Inc.
- Wall Street ends sharply higher after Powell comments
- Salesforce (CRM) shares slide despite topping earnings, revenue expectations
- Fed's Powell: Rate hikes to slow, but adjustment just beginning
- Snowflake shares plunge 13% despite Q3 beat
- Market turmoil and economic decline, before recovery in 2023, says JPM's Kolanovic
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
|SECURITIES AND EXCHANGE COMMISSION|
|Washington, D.C. 20549|
|Notice of Effectiveness|
|Effectiveness Date:||September 30, 2022|
|Submission Type:||POS AM|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- XORTX Announces Completion of Screening and Enrollment in Bridging Pharmacokinetics Study
- Share Buyback Transaction Details November 24 – November 30, 2022
- Proactive news headlines including AuKing Mining, Maximus Resources, Antilles Gold and Chase Mining Corporation
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!